Siller-Matula JM - Search Results

1

Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review.

Pordzik J, Jakubik D, Jarosz-Popek J, Wicik Z, Eyileten C, De Rosa S, Indolfi C, Siller-Matula JM, Czajka P, Postula M. Pordzik J, et al. Cardiovasc Diabetol. 2019 Aug 30;18(1):113. doi: 10.1186/s12933-019-0918-x. Cardiovasc Diabetol. 2019. PMID: 31470851 Free PMC article. Review.

2

Genetic Variability of SRC Family Kinases and Its Association with Platelet Hyperreactivity and Clinical Outcomes: A Systematic Review.

Milanowski L, Rasul F, Gajda SN, Eyileten C, Siller-Matula J, Postula M. Milanowski L, et al. Curr Pharm Des. 2018;24(5):628-640. doi: 10.2174/1381612824666171213105002. Curr Pharm Des. 2018. PMID: 29237371

3

Ticagrelor - toward more efficient platelet inhibition and beyond.

Kubisa MJ, Jezewski MP, Gasecka A, Siller-Matula JM, Postuła M. Kubisa MJ, et al. Ther Clin Risk Manag. 2018 Jan 17;14:129-140. doi: 10.2147/TCRM.S152369. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29398917 Free PMC article. Review.

4

Switching between P2Y₁₂ antagonists - From bench to bedside.

Gasecka A, Konwerski M, Pordzik J, Soplińska A, Filipiak KJ, Siller-Matula JM, Postuła M. Gasecka A, et al. Vascul Pharmacol. 2019 Apr;115:1-12. doi: 10.1016/j.vph.2019.01.003. Epub 2019 Jan 24. Vascul Pharmacol. 2019. PMID: 30685502 Review.

5

Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review.

Eyileten C, Soplinska A, Pordzik J, Siller-Matula JM, Postuła M. Eyileten C, et al. Clin Pharmacol Ther. 2019 Nov;106(5):993-1005. doi: 10.1002/cpt.1492. Epub 2019 Jul 1. Clin Pharmacol Ther. 2019. PMID: 31055838

6

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.

Gelbenegger G, Postula M, Pecen L, Halvorsen S, Lesiak M, Schoergenhofer C, Jilma B, Hengstenberg C, Siller-Matula JM. Gelbenegger G, et al. BMC Med. 2019 Nov 4;17(1):198. doi: 10.1186/s12916-019-1428-0. BMC Med. 2019. PMID: 31679516 Free PMC article.

7

Bioresorbable Vascular Scaffolds-Dead End or Still a Rough Diamond?

Jeżewski MP, Kubisa MJ, Eyileten C, De Rosa S, Christ G, Lesiak M, Indolfi C, Toma A, Siller-Matula JM, Postuła M. Jeżewski MP, et al. J Clin Med. 2019 Dec 7;8(12):2167. doi: 10.3390/jcm8122167. J Clin Med. 2019. PMID: 31817876 Free PMC article. Review.

8

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel.

Gasecka A, Nieuwland R, Budnik M, Dignat-George F, Eyileten C, Harrison P, Lacroix R, Leroyer A, Opolski G, Pluta K, van der Pol E, Postuła M, Siljander P, Siller-Matula JM, Filipiak KJ. Gasecka A, et al. J Thromb Haemost. 2020 Mar;18(3):609-623. doi: 10.1111/jth.14689. Epub 2020 Jan 9. J Thromb Haemost. 2020. PMID: 31833175 Free PMC article. Clinical Trial.

9

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing.

Ostrowska M, Kubica J, Adamski P, Kubica A, Eyileten C, Postula M, Toma A, Hengstenberg C, Siller-Matula JM. Ostrowska M, et al. Front Cardiovasc Med. 2019 Dec 3;6:176. doi: 10.3389/fcvm.2019.00176. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31850373 Free PMC article. Review.

10

Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.

Eyileten C, Postula M, Jakubik D, Toma A, Mirowska-Guzel D, Patti G, Renda G, Siller-Matula JM. Eyileten C, et al. J Clin Med. 2020 Apr 14;9(4):1120. doi: 10.3390/jcm9041120. J Clin Med. 2020. PMID: 32295160 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page